Calypso Biotech
Biopharmaceutical company, spin-off from Merck Serono, focused on developing antibody therapies up to clinical proof-of-concept for the treatment of diseases with large unmet medical needs.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
* | $250m | Acquisition | |
| Total Funding | 000k | ||
M Ventures(exited)
Eclosion(exited)
Gilde Healthcare(exited)
Inkef(exited)
Johnson & Johnson Innovation(exited)
Fountain Healthcare Partners(exited)
M Ventures(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.